Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03950154	TitleEstudio de la combinación de quimioterapia con inmunoterapia celular autóloga en el cáncer colorrectal recidivante y metastásico	Fase Fase 3	Date Added 2019-05-15	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Bevacizumab Injection [Avastin], capecitabine, oxaliplatin, PD1-T cells	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03947385	TitleEstudio de IDE196 en pacientes con tumores sólidos portadores de mutaciones GNAQ/11 o fusiones PRKC	Fase Phase 1, Phase 2	Date Added 2019-05-13	Ubicación California, United States New York, United States North Carolina, United States Ohio, United States Pennsylvania, United States Tennessee, United States Texas, United States Australia Canadá	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Binimetinib, Crizotinib, IDE196	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03940820	TitleInvestigación clínica de células CAR-NK específicas de ROBO1 en pacientes con tumores sólidos	Fase Fase 1/Fase 2	Date Added 2019-05-07	Ubicación China	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Células CAR-NK ROBO1	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03935893	TitleTransferencia adoptiva de linfocitos infiltrantes tumorales para cánceres sólidos avanzados	Fase Fase 2	Date Added 2019-05-02	Ubicación Pennsylvania, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Fludarabine + Cyclophosphamide combination, Tumor Infiltrating Lymphocytes (TIL)	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID PG545 (pixatimod) in combination with nivolumab	TitlePG545 (pixatimod) in combination with nivolumab	Fase Fase 1	Date Added 2019-04-26	Ubicación	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03925662	TitleMebendazol como tratamiento adyuvante del cáncer de colon	Fase Fase 3	Date Added 2019-04-24	Ubicación Egipto	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Folfox with avastin, Mebendazole	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03921684	TitleEnsayo de Nivolumab con FOLFOX tras quimiorradiación en pacientes con cáncer rectal	Fase Fase 2	Date Added 2019-04-19	Ubicación Israel	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas capecitabine, mFOLFOX6, Nivolumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03911557	TitleCombinación de Durvalumab y Tremelimumab en Tumores Sólidos Recurrentes Somáticamente Hipermutados	Fase Fase 2	Date Added 2019-04-11	Ubicación Kentucky, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Durvalumab y Tremelimumab	Etiquetas MSS/ MMRp
NCT ID NCT03874897	TitleChimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.	Fase Fase 1	Date Added 2019-03-14	Ubicación China	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas CAR-CLDN18.2 T-Cells, Chemotherapy, PD-1 Monoclonal Antibody	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03868228	TitlePIPAC para el tratamiento de las metástasis colorrectales peritoneales	Fase Fase 1	Date Added 2019-03-11	Ubicación Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 191 to 200 of 299 entries